No application received for EU authorisation of Covishield: European Medicines Agency

0
5

“For the COVID-19 vaccine Covishield to be evaluated for use in the EU, the developer needs to submit a formal marketing authorisation application to EMA, which to date has not been received,” the EMA said at a press briefing. 

LEAVE A REPLY

Please enter your comment!
Please enter your name here